STRATA Skin Sciences (SSKN) Other financing activities (2012 - 2023)
STRATA Skin Sciences recorded quarterly Other financing activities of $62000.0 in Q3 2023, down 97.35% quarter-over-quarter from $2.3 million in Q4 2018.
STRATA Skin Sciences' Other financing activities history runs 6 years deep, the most recent figure standing at $62000.0 for Q3 2023.
- In Q3 2023, Other financing activities changed N/A year-over-year to $62000.0; the TTM figure through Dec 2024 stood at $62000.0 (changed 0.0% YoY), while the FY2023 annual figure was $97000.0, changed N/A from the prior year.
- Other financing activities came in at $62000.0 for Q3 2023 at STRATA Skin Sciences, down from $2.3 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $62000.0 in Q3 2023 to a low of $62000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 62,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Dec 31, 2018 | 2.34 Mn |
| Dec 31, 2018 | 2.34 Mn |
| Jun 30, 2018 | -202,000.00 |
| Jun 30, 2018 | -202,000.00 |
| Mar 31, 2018 | 202,000.00 |
| Mar 31, 2018 | 202,000.00 |
| Sep 30, 2015 | 34,000.00 |
| Sep 30, 2015 | 34,000.00 |
| Dec 31, 2014 | -8,000.00 |
| Dec 31, 2014 | -8,000.00 |
| Mar 31, 2013 | -15.75 Mn |
| Mar 31, 2013 | -15.75 Mn |
| Sep 30, 2012 | 105,056.00 |
| Sep 30, 2012 | 105,056.00 |
| Jun 30, 2012 | 194,649.00 |
| Jun 30, 2012 | 194,649.00 |
| Mar 31, 2012 | 4,293.00 |
| Mar 31, 2012 | 4,293.00 |